News|Articles|January 21, 2026
Investigation of Separation Conditions and Prep Purification of GLP-1 Receptor Agonist Semaglutide
Author(s)Shimadzu Corporation
The article describes a comprehensive automated prep purification workflow targeting semaglutide, a GLP-1 receptor agonist, using dedicated method development software to automatically optimize a gradient profile and search for conditions that meet the specified separation criteria. This was followed by scale-up to purification scale and streamlined confirmation of the purities of collected fractions using benchtop MALDI-TOF MS.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Waters Completes Combination with BD Biosciences and Diagnostic Solutions Businesses
2
International Day of Women and Girls in Science 2026: Inspiring the Next Generation of Women in Chromatography
3
LC–MS Determination of PFAS Distribution in Porcine Tissues for Food Safety Monitoring
4
Chromatographic Characterization and Anticancer Activity of Scorpio fuscus Venom in Colorectal Cancer Models
5